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Opportunistic infections occur with greater
frequency or severity in patients with impaired
host defenses. Growing numbers of HIV-infected
persons, transplant recipients, and elderly
persons are at increased risk.
Alison Grant, London School of Hygiene and
Tropical Medicine, discussed opportunistic infec-
tions due to HIV. In 1997, more than 30 million
HIV-infected persons lived in the world, with
more than two thirds of them in sub-Saharan
Africa and an additional 20% in Asia and Latin
America. Assessments of the prevalence and
incidence of opportunistic infections in these
areas and comparability of the available data are
hampered by limited access to care, diagnostic
capabilities, and surveillance data. Despite these
limitations, we know that tuberculosis (TB) is the
most frequent serious opportunistic infection in
the developing world. Other such infections
common in sub-Saharan Africa include septice-
mia (of which nontyphoid salmonella is the most
common cause), toxoplasmosis, and bacterial
pneumonia. Pneumocystis carinii infection, for
unknown reasons, is uncommon among adults in
East and West Africa but appears to be more
common in South Africa. Penicillium marneffei
infection, common in Thailand, is an example of
an opportunistic infection of importance in a
specific region; risk factors in these regions are
largely unknown. Additional challenges are
posed by the different HIV subtypes in the
developing world and the possibility that some
may be associated with a differential risk for
opportunistic infections. Prevention efforts in
developing countries have been limited. More
work is needed to evaluate prophylactic regimens
appropriate to different regions. Prevention of TB
with isoniazid; of pneumocystosis, toxoplasmosis,
and some bacterial infections with cotrimoxazole;
and of pneumococcal infections with 23-valent
pneumococcal vaccine have potential.
Robert Hogg, University of British Colum-
bia, discussed the remarkable changes in the
natural history of HIV in North America,
specifically in British Columbia, as a result of
highly active antiretroviral therapy (HAART).
Of more than 5,000 HIV-infected persons
receiving care in British Columbia, more than
2,000 are receiving HAART. HIV viral loads
have been reduced to undetectable levels in
approximately half of these patients, with
corresponding decreases in the incidence of
opportunistic infections, hospitalizations, and
deaths. However, even for persons who have
access to the therapy, these successes may be
short-lived as resistance to HAART becomes
more widespread. HAART use has resulted in
new syndromes that may occur soon after
therapy, probably representing preexisting,
subclinical infections that are unmasked by the
immunologic improvement that accompanies
HAART; these syndromes include lymphadeni-
tis associated with Mycobacterium avium
complex, cytomegalovirus retinitis, and miliary
TB on chest X-ray. Hepatitis C infection,
common in HIV-infected injection drug users,
may pose increasing problems as coinfected
persons live longer. Therefore, surveillance for
old and new syndromes remains critical even
with the reduced incidence of opportunistic
infections that has been associated with
HAART.
Robert Rubin, Harvard University and
Massachusetts Institute of Technology, discussed
opportunistic infections in hematopoietic stem
cell (bone marrow) and solid-organ transplant
recipients; the number of these transplant
recipients has increased dramatically in the
United States in the past decade. The opportunis-
tic infections in these patients originate from
endogenous flora (e.g, invasive candidiasis), from
the general (nonhospital) environment (e.g,
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histoplasmosis, TB, disseminated strongyloidi-
asis), or from the hospital environment (e.g,
aspergillosis, legionellosis, and infections with
vancomycin-resistant enterococci or multiply
resistant gram-negative bacteria). These infec-
tions characteristically occur in a time-depen-
dent pattern posttransplant, corresponding with
the nature of the immunodeficiency. For
example, in bone marrow transplant recipients,
infections within 1 month of transplantation
(pre-engraftment) occur as a result of neutrope-
nia and disruption of mucosal surfaces; infections
that occur in the second or third months are due
to deficiencies in cell-mediated immunity and are
more frequent in the setting of graft versus host
disease. In solid-organ transplant recipients,
infections within the first month are generally
associated with technical problems related to
surgery; infections that occur later are due to
immunodeficiency associated with immunosup-
pressive therapy. These timetables are useful in
that infections that are unusual or occur outside
the expected time frame may serve as sentinels
for emerging opportunistic infections. Research
priorities in this area include development of
therapies that will enhance successful transplan-
tation without increasing the risk for opportunis-
tic infections, strategies to reduce the risk of
drug-resistant opportunistic infections, and
greater understanding of the role of cytokines in
the relationship between graft versus host
disease and opportunistic infections.
Carol Kauffman, University of Michigan and
the Ann Arbor Veterans Administration Medical
Center, discussed infections in the elderly, a
population that is increasing in the United
States and worldwide. Persons >65 years of age
already constitute approximately one eighth of
the U.S. population; this proportion is expected
to double in the next 50 years. Elderly persons
have defects in T-cell immunity that result in
increased incidence and death from TB. B-cell
defects result in increased susceptibility to
Streptococcus pneumoniae and respiratory
syncytial virus and a decreased response to 23-
valent pneumococcal vaccine. Elderly persons
are at increased risk for cancer, so various
treatments associated with immunosuppres-
sion (such as organ transplantation and
aggressive cancer chemotherapy) are increas-
ingly being used in this population. Chronic
corticosteroid therapy is frequently used for
treatment of temporal arteritis. Although HIV
infection is relatively uncommon in the elderly,
when it does occur, it is likely to go undiagnosed.
Because of higher rates of hospitalization, elderly
persons are more susceptible to nosocomial
infections (including those caused by antibiotic-
resistant organisms). Moreover, the elderly are
more likely to reside in long-term care facilities,
which may serve as sources or amplifiers of
infections such as influenza. Susceptibility to
infection may be further increased by malnutri-
tion, diabetes, and chronic renal failure. Finally,
healthy, more affluent older persons are at risk
for infections associated with travel.
In summary, opportunistic infections are a
threat in the increasing populations of
immunocompromised persons. In these popula-
tions, opportunistic infections pose challenges for
surveillance and determination of risk factors,
including those for infection with antibiotic-
resistant organisms.